In a study that tracked serum levels of neuro-injury and neurodegeneration markers in COVID-19 patients over time, the levels of Aβ42, TDP-43, and NF-L decreased during a period following hospitalization but eventually returned to baseline levels in surviving patients. Here, TARDBP is linked to COVID-19.